When he ran for president in 2008, Mayor Giuliani made the claim that he was lucky to be treated for his prostate cancer as a citizen of the United States because the survival rate was 82 percent, compared to 44 percent in Britain. While these statistics are technically accurate, a closer look at them will […]
Archives for 2014
Sonablate (now Sonacare) Reports Excellent Sales in 2013
Sales of the Sonablate HIFU device for non-invasive treatment for localized prostate cancer were higher than expected in 2013. SonaCare Medical, the developer of the device, reported a sales total of six Sonablate HIFU devices that year, which matches the prior year’s sales record as interest in precision guided treatment technologies for prostate cancer continued […]
HIFU Comes to the UK for Prostate Cancer Treatment
For prostate cancer patients in the United Kingdom, 2014 brought excellent news. For the first time on March 3, 2014, High Intensity Focused Ultrasound (HIFU) became a treatment option for patients at Southampton General Hospital. Until this change, the treatment had only been available to private patients who were able to pay for it out […]
New Recommendations for Kidney Disease Patients
Bert Vorstman MD, MS, FAAP, FRACS, FACS www.urologyweb.com A new recommendation for patients with chronic kidney disease asks physicians to perform a full lipid profile at first presentation of the condition. The new recommendations come from a work group working on behalf of the Kidney Disease: Improving Global Outcomes organization. According to the guidelines, measuring […]
Over-Diagnosis/Treatment Risk & Cancer Screening
Bert Vorstman MD, MS, FAAP, FRACS, FACS www.urologyweb.com Overdiagnosis and overtreatment of prostate cancer is a very real risk, yet very few men are actually told of the potential for this risk. In fact, patients are not regularly informed of the risks of overdiagnosis and overtreatment for most types of cancers. In one online study […]
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- Next Page »